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Purpose. Retinitis pigmentosa is the most common inherited retinal dystrophy. The factors 
associated with visual acuity in patients with other retinal diseases are well known, but are poorly 
understood in patients with retinitis pigmentosa. This knowledge is useful for prognosis and to 
support secondary endpoints in clinical trials.      
Methods. We conducted a cross-sectional study of consecutive patients recruited from the inherited 
retinal disease service from January 2012 to December 2012. Central macular thickness (CMT) was 
measured using spectral domain optical coherence tomography.  
Results. Data were available for 81 patients and 162 eyes. After multivariable analyses, older age, 
earlier age of onset of symptoms, and thicker CMT were associated with lower visual acuity. Gender 
and inheritance pattern were not associated with visual acuity. Each decade older age, younger age 
of onset, and thicker CMT was associated with 0.12, 0.10 and 0.11 worse LogMAR units of visual 
acuity, respectively (P<0.05 for all).  
Conclusions. Age, age of onset, and CMT are associated with visual acuity and important factors to 






Retinitis pigmentosa (RP) or rod cone dystrophy is the most common inherited retinal dystrophy. It is 
a heterogeneous, progressive disorder with no proven treatments despite much ongoing research.1;2  
Cystoid macular edema is a known complication that can occur in patients with RP.1 Unlike other 
retinal diseases where cystoid macular edema also occurs such as age-related macular degeneration 
and diabetic retinopathy, little is known about the factors associated with good visual acuity in 
patients with RP. Such information is useful as it provides insights into pathophysiology and suggests 
secondary or surrogate endpoints for testing new treatments. For example, the association between 
central macular thickness (CMT) and visual acuity is well established in age-related macular 
degeneration, diabetic macular edema and retinal vein occlusions and CMT is a recognised 
secondary endpoint in treatments trials of these diseases.3-5 The association between CMT and 
visual acuity has been studied in patients with RP, but results have been inconsistent, partly because 
studies included patients with and without cystoid macular oedema.6-9 We therefore performed a 
cross sectional study to determine the factors associated with visual acuity in patients with RP and 
thickened central macula from cystoid macular edema.  
 
Methods 
We collected data on 81patients seen in the inherited retinal disease clinics at Moorfields Eye 
Hospital NHS Foundation Trust, London, UK from January 2012 to December 2012 inclusive. Patients 
were included in the study if they had macular oedema secondary to RP. Exclusion criteria included 
macular edema secondary to other causes such as epiretinal membrane or vitreous traction. The 
study was approved by the Human Research Ethics Committee of Moorfields Eye Hospital NHS 
Foundation Trust and adhered to the tenets of the Declaration of Helsinki. Further details are 
provided elsewhere.10   
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The diagnosis of RP was based on a history of nyctalopia, peripheral visual field constriction, 
characteristic fundus findings on ophthalmoscopic examination, fundus autofluorescence 
abnormalities such as peripheral hypoautofluoresence and central peri-macular 
hyperautofluorescent rings, and in some cases full field electroretinogram testing. Electroretinogram 
testing was performed according to the International Society for Clinical Electrophysiology of Vision 
(ISCEV) standards.11 Pedigrees were constructed and RP was categorised as autosomal dominant 
(e.g. one affected parent or child, equal gender distribution), autosomal recessive (e.g. no affected 
parents, multiple affected siblings, consanguinity) and X-linked RP (e.g. males only, no male-to-male 
transmission, mothers may have signs). 1 A limited number of patients had a molecular diagnosis.  
Snellen best-corrected visual acuities were documented and converted into logarithm of the minimal 
angle of resolution (logMAR) values for statistical analysis. The Spectralis HRA + OCT with viewing 
module version 5.1.2.0 (Heidelberg Engineering, Heidelberg, Germany) was used to acquire 
autofluorescence images as well as SD-OCT images. The SD-OCT protocol included a dense horizontal 
linear scan centered on the fovea and values of CMT were taken from the 1mm2 central retinal 
subfield.  
SAS version 9.2 (SAS Institute, Cary NC) was used for analyses. Multivariable models were 
constructed with LogMAR visual acuity as the outcome variable, and age, gender, age of onset, 
inheritance pattern and CMT as the study variables. Generalised estimating equation models were 
used to account for the correlation between eyes. Pearson correlation coefficients were calculated 
for factors associated with visual acuity. Scatterplots were constructed using Excel.  
Results 
Table 1 shows the baseline characteristics of the 81 patients (162 eyes) included in the study. The 
mean age of patients was 41.9 years, and mean age of onset of symptoms was 23.4 years. Females 
comprised 44.4% of the sample, 29.6% of patients had an inheritance pattern consistent with 




We examined the independent associations of the factors above with visual acuity and found that 
older age, earlier age of onset of symptoms, and thicker CMT were associated with worse visual 
acuity (Table 2). Gender and inheritance pattern were not associated with visual acuity. Each decade 
older age, younger age of onset, and thicker CMT was associated with 0.12, 0.10 and 0.11 worse 
LogMAR units of visual acuity, respectively (P<0.05 for all). Figure 1 shows the scatterplot of visual 
acuity and CMT with a trendline showing increasing LogMAR visual acuity with increasing CMT. The 
correlation between visual acuity in LogMAR units and age, age of onset, and CMT was r=0.10 
(p=0.19), 0.15 (p=0.14) and 0.20 (p=0.01), respectively. (data not shown).   
 
Discussion 
Knowledge of the factors associated with visual acuity in retinal diseases can provide insight into 
prognostic indicators and suggest secondary endpoints for clinical trials of therapeutic agents. This 
has been examined extensively in other major retinal diseases, but few studies have investigated this 
in RP. We report that in patients with retinitis pigmentosa and cystoid macular edema, older age, 
earlier age of onset and thicker CMT are associated with worse visual acuity. Gender and inheritance 
pattern (autosomal recessive versus autosomal dominant) were not associated.  
 
Older age and earlier age of onset are associated with poorer visual acuity as these are markers of 
longer duration of disease and greater degree of photoreceptor degeneration. Earlier age of onset 
may also be a measure of more severe disease,1 and decline in photoreceptor function may 
accelerate with age.1;12 Greater CMT is an indicator of more severe cystoid macular edema and is 
associated with poorer vision in neovascular age related macular degeneration,13 diabetic macular 
oedema14 and retinal vein occlusion15 due to distortion of photoreceptors and bipolar cells. The 
correlation of CMT with visual acuity in our study was weak at r=0.20, which is comparable to that 
reported for cystoid macular edema in neovascular age-related macular degeneration (r=0.25)13 and 
lower than that reported for diabetic macular edema (r=0.56)14. A study in patients with RP but 
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without clinical cystoid macular edema (i.e visible cysts on OCT) reported a U shaped relationship 
where patients with severe retinal thinning (due to loss of outer retinal and photoreceptor layers) 
and mild retinal thickening (from presumed subclinical cystoid macular oedema) were found to have 
poorer vision than those with normal retinal thickness6. Our results extend this to show there is a 
clear relationship between retinal thickening from clinical cystoid macular oedema and visual acuity. 
Together these results suggest that SD-OCT CMT may be a useful objective endpoint for clinical trials 
of treatments for RP. 
 
Strengths of this study include the moderately large number of patients, careful phenotyping, 
pedigrees to determine inheritance, objective measurement of CMT on SD-OCT and multivariable 
adjustment in analyses. A limitation of the study is that there were very few patients with X-linked 
inheritance and we are unable to draw conclusions regarding this form of disease. The majority of 
patients did not have a molecular diagnosis. Genotype may be an important factor associated with 
visual acuity, but over 100 genes/loci have been identified in RP and testing for all of them is 
currently  prohibitively expensive.2 This may become a more feasible option for future studies as the 
cost of genotyping continues to decrease. Another limitation of this study is that electrophysiology 
was only performed in patients in whom there was uncertainty regarding the diagnosis. The 
amplitude of the central segment of multifocal electroretinograms may correlate with visual acuity 
but was not routinely measured in this study.16  
Conclusion 
We report that age, age of onset of symptoms, and CMT are independently associated with visual 
acuity in patients with RP and cystoid macular edema. Data on these factors should be collected in 
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Figure 1. Scatterplot of LogMAR visual acuity against central macular thickness. The trendline shows 
a modest positive correlation.  
